
Thousands of Urine and Tissue Samples Are in Danger of Rotting After Staff Cuts at a CDC Laboratory
Apr 17, 2025 11:48 AM Workers who recently lost their jobs at the National Institute for Occupational Safety say they're concerned that there's no plan for managing biological samples tied to research projects. Photo-illustration: WIRED Staff; Getty Images
Seven federal workers who abruptly lost their jobs in recent weeks say they are worried that thousands of biological samples—from human urine to frozen rodent organs—may be left to rot in a government laboratory in West Virginia. The workers left behind the samples, which they say include lungs, spleens, and brains collected from rats and mice, after the Trump administration laid off or placed on administrative leave about two-thirds of the staff working at facilities managed by the National Institute for Occupational Safety and Health (NIOSH) earlier this month.
The NIOSH researchers collected the tissue samples as part of experiments to determine how Americans may be impacted by chemicals and other substances they are exposed to at their jobs. Some of the samples are stored in a refrigerator that needs to be kept at -112 Farenheit at all times, while others are stored in liquid nitrogen. Unless someone inside the federal government continues to ensure the liquid nitrogen doesn't totally evaporate, the samples will eventually defrost and begin to rot, according to three staff researchers who work with such materials.
'You can't really store them very long in a regular freezer—they won't be viable,' says Kyle Mandler, a toxicologist at the Morgantown NIOSH facility who was placed on administrative leave during the recent so-called reduction in force at the agency. 'That clock is ticking, and every day is closer.'
The Centers for Disease Control and Prevention, which has historically overseen NIOSH, referred WIRED's questions about the fate of the samples to the Department of Health and Human Services. HHS declined to comment on the record. But hours after WIRED contacted the agency, a current NIOSH staffer said that some remaining employees were abruptly told by higher-ups that the liquid nitrogen levels were being 'monitored.'
One NIOSH researcher who lost their job tells WIRED that if the samples aren't left to rot, they will probably be destroyed—a process that would involve placing them into biohazard bags and paying a third-party company to incinerate them. It's unclear what may happen to other materials in the lab, such as chemicals used in experiments. The researcher said that a large shipment of chemicals had arrived the morning of the layoffs.
The Morgantown facility also houses historical tissue samples, including what the CDC describes as a ''time capsule' of diseased human lungs from black lung victims. Current and former NIOSH employees who spoke to WIRED say they are not aware of any plans for these samples. 'I have seen and held those samples in my hands,' Mandler tells WIRED. 'There is nothing like that tissue bank anywhere in the world.'
Created as part of the Occupational Safety and Health Act signed into law by President Richard Nixon in 1970, NIOSH is responsible for conducting research into causes of work-related injuries and deaths. It also helps inform federal workplace regulations, such as safe exposure levels for various toxic substances.
In late March, HHS Secretary Robert F. Kennedy Jr. announced that NIOSH would be moved from the CDC to a new entity called the 'Administration for a Healthy America' as part of a 'dramatic restructuring' plan that would involve eliminating 10,000 full-time employees at HHS.
Cathy Tinney-Zara, a worker at NIOSH's Pittsburg facility who spoke to WIRED in her capacity as the union representative, says that before they lost their jobs, the researchers at the Morgantown facility had been actively studying how Gulf War soldiers were affected by exposure to Mustard Gas, how pregnant workers have been affected by exposure to PFAS chemicals, and how manufacturing workers contract lung fibrosis after inhaling nanoparticles.
Two Morgantown researchers—who like others in this story, asked to remain anonymous to avoid professional repercussions—say that their laid off colleagues were also researching how agricultural workers are impacted by inhaling dust from hemp plants, and a possible link between exposure to chemical disinfectants and asthma. The lab was also about to begin developing a rapid toxicity test for chemicals that US troops may be exposed to while they are deployed.
Mandler says he was researching why some people who manufacture, cut, and install stone countertops were starting to get silicosis—a potentially fatal lung scarring and inflammation disease that makes it difficult to breathe—after just a few years on the job. Generally, he says, workers tend to get the disease after spending decades in the field.
'I have listened to men younger than me sit across the table and talk about how they feel like they're drowning in their own lungs because of these exposures, and they can't see their children grow up,' Mandler says.
He adds that some of the NIOSH staffers who lost their jobs were testing how lung tissue reacts after being exposed to the dust from different brands of commercial synthetic quartz. The material, commonly used in countertops, is thought to cause more severe lung damage than exposure to pure natural quartz, Mandler says. He believes something in the manufacturing process may be to blame, but now that his research team at NIOSH has been dismantled, Mandler fears it will take longer for the scientific community to find the root cause.
Three Morgantown researchers who were affected by the job cuts tell WIRED that they have not received any information about who would be in charge of the facility's biological samples after the reduction in force, how custody of them could be transferred, or what their ultimate fate may be. Since entire divisions at NIOSH were eliminated, one researcher says, they don't even know who could take responsibility for the samples they oversaw at the facility.
Another researcher says that when the layoffs happened, the only instruction they received was 'to destroy our purchase and travel cards, and maintenance was available to help us take personal items to our cars.'
The researcher says that CDC guidelines direct employees to keep physical samples and accompanying personally-identifiable information under lock and key, and only certain authorized staff are permitted to access them. 'My colleagues and I took this responsibility very seriously,' the researcher tells WIRED. 'Many are worried about samples and what will become of them, sensitive and otherwise.'
Even before the recent reduction in force, Mandler and two other laid off researchers say that a federal spending freeze ordered by the Trump administration in January had reduced the Morgantown facility's supply of liquid nitrogen to 'critical' levels. It took several weeks to restart the shipments.
In addition to samples taken from rodents, NIOSH's frozen tissues include commercially produced immortalized cell lines—cells that can proliferate indefinitely and enable small tissue samples to grow into larger ones that can more easily be experimented on. Mandler tells WIRED that one small vial of immortalized cells cost about $600, and his team alone had almost 100 of them ready to use before they abruptly got laid off. Across all of the different research teams at NIOSH, Mandler estimates that the frozen vials and tissue samples they have bought would be worth 'millions of dollars' in total.
The mice and rat cells come from live animals housed directly inside the Morgantown facility, which are usually cared for by a veterinarian and other support staff. The lab's Morgantown's attending veterinarian, Stephen Harvey, also lost his job as part of the reduction in force, according to a comment he made on LinkedIn.
Mandler says that, despite losing his job, Harvey has continued to work and care for the animals. Harvey declined an interview request from WIRED, but said in a LinkedIn message that the lab has 'not euthanized any animals' and is trying to 'find good solutions for them.' Tinney-Zara says that about 600 of the approximately 700 rodents at the Morgantown lab have been relocated to a nearby university.
One researcher at NIOSH's Pittsburgh facility—whose work has focused on developing and modifying machines for monitoring the amount of dust and chemicals in the air—says they fear expensive instruments purchased by the government could also go to waste across different NIOSH facilities.
The researcher says that hundreds of machines in NIOSH's Pittsburgh facility, many of which are worth tens of thousands of dollars, have to be used, calibrated, and serviced frequently in order to continue working properly. They point specifically to a device called an X-ray diffractometer, an instrument for identifying the elements in small physical samples, which they say is supposed to run constantly.
From their firsthand experience during COVID, the researcher says they know that fixing a long-dormant machine is expensive and can take many weeks, if it succeeds at all. Now, they worry that these instruments, and their specialized testing capabilities, will be abandoned and go to waste.
'We could be in a situation to leave behind millions of dollars of equipment and infrastructure in the labs,' the researcher tells WIRED.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
36 minutes ago
- Yahoo
Here's why SpaceX faces a bright future as government contractor despite Musk-Trump divorce
The public breakup between Elon Musk and President Trump has cast a pall over the future of SpaceX – but the mogul's company should remain on a solid trajectory because the two sides need each other. Trump has counted on his estranged First Buddy's privately owned firm to fulfill the administration's plans for NASA to return to the moon, ongoing operations at the International Space Station, a reported classified deal with US intelligence to build hundreds of spy satellites and expanding internet access to rural parts of America. SpaceX – known for building and launching rockets, and the Starlink satellite internet network – has approximately $22 billion in government contracts on the books, according to Reuters. That includes a roughly $5 billion deal to build the Dragon spacecraft for use by NASA, which Musk threatened to decommission in his unhinged social media rants aimed at Trump – only to later reverse course hours later. Trump threatened to end Musk's federal contracts in response to the verbal onslaught, which included the allegation that Trump is 'in the Epstein files' and that he would have 'lost the election' without his help. 'Trump could certainly cancel most deals and contracts if he wants but the government may still have to pay them – depends on the contract details,' a Republican consultant connected with Trump, who was granted anonymity to speak candidly about the feud, told The Post on Friday. The two men appeared no closer to a detente, with Trump refusing to get on the phone with his former DOGE cost-cutter and largest campaign benefactor after he blasted the White House-backed 'One Big Beautiful Bill.' While that makes for great theater, the split probably works in both of their favors, according to the source. 'Trump and Elon both got what they wanted here,' the GOP consultant said. 'Elon was able to distance himself from Trump in a public enough way to get his businesses back on track and Trump was able to have all of the MAGA warriors who were questioning the bill shut up or even defend it so they could defend Trump and prove they took his side.' SpaceX 'will be fine' despite the fireworks, the source added. White House Press Secretary Karoline Leavitt declined to comment on the war of words. 'President Trump is focused on making our country great again and passing the One Big Beautiful Bill,' she said. SpaceX did not immediately return a request for comment. As the founder, chairman and CEO of SpaceX, Musk is in total control with 79% of the company's voting shares as of 2023, according to a filing at the time. The closely held firm recently secured a $350 billion valuation. Overall, Musk and his businesses that also include Tesla, brain chip firm Neuralink and The Boring Company have received at least $38 billion in government contracts, loans, subsidies and tax credits, according to a recent Washington Post analysis. If Trump does decide to go to DefCon 5 on Musk, the billionaire's alleged drug use could be used as one possible lever to wriggle out of the SpaceX contracts. During Trump's first term in office in 2019, Bloomberg reported that the Pentagon was reviewing Musk's SpaceX security clearance after he smoked marijuana during an appearance on 'The Joe Rogan Experience' podcast. While Musk has strenuously denied misusing drugs, House Democrats this week requested details from Trump on whether he had any knowledge of Musk working 'under the influence.' The possible loss of government contracts would not be 'catastrophic' for Musk or his rocket company. 'SpaceX has developed itself into a global powerhouse that dominates most of the space industry, but there's no question that it would result in significant lost revenue and missed contract opportunities,' Justus Parmar, CEO of SpaceX investor Fortuna Investments, told Reuters. Meanwhile, MAGA firebrand Steve Bannon called for the South African-born Musk to be deported – and floated the possibility that Trump could use a Korean War-era statute called the Defense Production Act to enable a federal takeover of the privately owned company. However, the headline-grabbing proposal is likely a nonstarter. 'There's no way Bannon's idea of just taking over private companies works out long term, both because it would be litigated and because other companies would keep the US government at arm's length to avoid future similar issues,' the consultant said. 'Neither outcome is workable.'
Yahoo
2 hours ago
- Yahoo
Pharmaceutical company AstraZeneca sues Utah Attorney General over discount medication law
SALT LAKE CITY () — The pharmaceutical company AstraZeneca has filed a federal lawsuit against Utah Attorney General Derek Brown and Utah Insurance Commissioner Jon Pike over a recent law that is intended to allow more pharmacies to have access to drug discount programs. In a lawsuit filed May 23, AstraZeneca alleges that Utah SB 69 is unconstitutional. The law was introduced and passed in the 2025 General Assembly, and it went into effect on May 7. The law prohibits drug manufacturers from restricting pharmacies from working with 340B entities, which help pharmacies and patients access medications at a discounted price. Senator Lee responds to the Trump-Musk feud The 340B Drug Pricing Program is a that 'enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services,' according to the Health Resources and Services Administration (HRSA) website. It means that drug manufacturers participating in Medicaid agree to provide 'outpatient drugs to covered entities at significantly reduced prices.' All organizations need to be registered and enrolled in the 340B program in order to purchase discounted medications. The law that established the 340B Program, Section 340B(a)(4) of the Public Health Service Act, specified certain types of for the program, such as medical centers that serve rural and other underserved communities and clinics that specialize in particular diseases like HIV/AIDS. SB 69 expands the scope, requiring drug manufacturers to provide the discounts to third-party pharmacies that are contracting with 340B entities, and this is what AstraZeneca is claiming is unconstitutional in its lawsuit. Utah House Republicans elect new leadership members The lawsuit states that because price controls 'disincentivize innovation and destabilize markets,' Congress chose to specifically limit the types of organizations that are eligible in Section 340B. The suit notes that for-profit pharmacies like Walgreens or CVS were not included as eligible, and there have already been several federal court cases ruling that block efforts to require drug manufacturers to provide discounts to contracted pharmacies. AstraZeneca claims in its suit that SB 69 'requires pharmaceutical manufacturers to offer 340B-discounted pricing for sales at an unlimited number of contract pharmacies,' expanding 340B discounts to 'an entirely new category of transactions not covered by Section 340B itself.' The suit alleges that SB 69 directly conflicts with federal law requirements, and therefore, it cannot be enforced against Astrazeneca or other drug manufacturers. AstraZeneca is asking the court to declare SB 69 unconstitutional and to order that Utah AG Derek Brown and Insurance Commissioner Jon Pike not enforce the law against AstraZeneca. Musk floats 'The American Party' after Trump tiff Myths VS Facts: What health officials want you to know about the MMR vaccine Good4Utah Road Tour: Willard Bay State Park Lori Vallow Daybell back in court, charged with conspiracy to murder ex nephew-in-law Man charged with assault for allegedly attacking and strangling neighbor Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
2 hours ago
- Yahoo
UCSD students protest Trump cuts to science research funding
SAN DIEGO (FOX 5/KUSI) — For the second time this year, students and faculty at the University of California, San Diego (UCSD) staged a protest outside Geisel Library, demanding the federal government reverse deep education funding cuts imposed by the Trump administration — cuts they say are threatening research, jobs and the future of scientific innovation. Dozens of protesters gathered on campus, holding signs and sharing personal stories about how the loss of federal research grants is impacting their work and well-being. Dozens possibly detained by federal officials amid immigration raids in Los Angeles 'This year has been filled with many moments of insecurity,' said Eleanor Ketterer-Sykes, a first-year Ph.D. student in the neuroscience program. 'UCSD is one of the best science schools in the country because of its renowned research labs, you have access to labs at the Salk Institute, Sanford and Scripps as well as the VA Hospital — but that future is in jeopardy.' The Trump administration has canceled hundreds of research grants in recent months, citing concerns over 'ideologically driven science.' The cuts have targeted studies ranging from HIV prevention to violence prevention in children. UCSD Chancellor Pradeep Khosla warned in an April letter that the university stands to lose between $75 million and $500 million annually as a result. 'As of May 30, there have been more than 150 federal grants terminated, resulting in a loss of $30 million,' said Lisa Eyler, a UCSD psychiatry professor. 'These cuts are already leading to layoffs among instructors, staff scientists, and support personnel like librarians.' 'No Kings Day' protests planned across California on June 14 The ripple effects could be felt beyond UCSD. Stanley Maloy, emeritus professor of microbiology at San Diego State University, said the cuts threaten the pipeline of future scientists and engineers. 'Reduced positions mean talented students are left behind,' Maloy said. 'As this innovation workforce dries up, our economy is going to suffer.' Eyler echoed those concerns, warning of a generational loss in scientific progress. 'There will be a gaping hole in the pipeline of future scientists, engineers and healthcare providers, which could result in the potential loss of an entire generation of great scientific thinkers,' she said. Thousands in San Diego protest cuts to federal education funds For Ketterer-Sykes, the issue is personal. She entered the neuroscience program hoping to make life-saving breakthroughs. 'So many people rely on scientific innovation — whether it be to find cures for diseases like tuberculosis or Alzheimer's disease,' she said. 'It really is vital to humanity.' While the exact financial toll remains uncertain, university leaders say the impact is already being felt — and may only get worse. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.